Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock ...Middle East

ATLANTA, June 18, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced the closing...

Hence then, the article about inhibikase therapeutics announces closing of follow on offering of common stock was published today ( Saturday 19/06/2021 - 02:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock )

Also on site :

• The Oil Shock Is Worse Than You Think
• Kremlin explains Easter ceasefire
• AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026